03 Profile
Hansard to 16 November 2026 · 31,598 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Dementia
James Condulis
Stifel analyst
Quoted in the press, across 1 topic since 14 Oct 2026
02 Quoted on · 1 of 29 topics
James Condulis: key facts
- Kind of voice
- Sector leader
- Role
- Stifel analyst
- Quoted on
- Dementia
- Press coverage
- Quoted in the press
- Most recently quoted
- 14 Oct 2026
04 On the record · press
What James Condulis has said
- biopharmadive.com
Where James Condulis has been quoted
- Experimental Arrowhead RNAi drug hints at Alzheimer’s benefitbiopharmadive.com · 14 Oct 2026
How we found the articles that name James Condulis: we searched news for these terms.
- dementia
- dementia care
- Alzheimer's
- memory clinic
- dementia diagnosis
- dementia strategy
Also searched with “dementia” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Dementia
Verbatim
“The results "look compelling and, with subcutaneous delivery, arguably look [better] than what we've seen" with other drugs designed to cross the blood-brain barrier”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.